Shukla Alok, Hashiguchi Naoyuki, Chen Yu, Coimbra Raul, Hoyt David B, Junger Wolfgang G
Department of Surgery/Trauma, University of California San Diego, San Diego, California 92103, USA.
Shock. 2004 May;21(5):391-400. doi: 10.1097/00024382-200405000-00001.
Inflammation and immunosuppression can cause acute respiratory distress syndrome, multiple organ failure, and sepsis, all of which are lethal posttraumatic complications in trauma patients. Prevention of the inflammation and immunosuppression has been a main focus of trauma researcher for many years. Recently, hypertonic resuscitation has attracted attention as a possible therapeutic approach to counteract such deleterious immune responses in trauma patients. We have begun to understand how hypertonic fluids affect immune cell signaling, and a number of experimental and clinical studies have started to reveal valuable information on the clinical efficacy and the limitations of hypertonic resuscitation fluids. Knowledge of how osmotic cues regulate immune cell function will enable us to fully exploit the clinical potential of hypertonic resuscitation to reduce inflammatory and anergic complications in trauma patients.
炎症和免疫抑制可导致急性呼吸窘迫综合征、多器官功能衰竭和脓毒症,所有这些都是创伤患者创伤后致命的并发症。多年来,预防炎症和免疫抑制一直是创伤研究人员的主要关注点。最近,高渗复苏作为一种可能的治疗方法引起了关注,以对抗创伤患者中这种有害的免疫反应。我们已经开始了解高渗液如何影响免疫细胞信号传导,并且一些实验和临床研究已经开始揭示关于高渗复苏液临床疗效和局限性的有价值信息。了解渗透信号如何调节免疫细胞功能将使我们能够充分利用高渗复苏的临床潜力,以减少创伤患者的炎症和无反应性并发症。